)
NRx Pharmaceuticals (NRXP) investor relations material
NRx Pharmaceuticals Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for March 23, 2026, to be held virtually at 10:00 a.m. Eastern Time.
Proxy materials, including the Proxy Statement and Annual Report, are available online for shareholder review.
A supplement was issued to correct proposal numbering errors on the proxy card and cover letter; all other information remains unchanged.
Voting matters and shareholder proposals
Election of Chaim Hurvitz and Michael Taylor as Class I directors to serve until the 2028 annual meeting.
Approval of an amendment to the 2021 Omnibus Incentive Plan.
Ratification of Weinberg & Company, P.A. as independent auditors for the fiscal year ending December 31, 2025.
Non-binding advisory vote on the compensation of named executive officers.
Board recommends voting “For” all proposals.
Board of directors and corporate governance
Board nominees for Class I directors are Chaim Hurvitz and Michael Taylor.
Directors, if elected, will serve until the 2028 annual meeting or until successors are appointed and qualified.
- Board recommends approval of director elections, equity plan amendment, auditor, and say-on-pay.NRXP
Proxy Filing23 Feb 2026 - Proxy covers director elections, equity plan changes, auditor ratification, and executive pay vote.NRXP
Proxy Filing13 Feb 2026 - Accelerated drug filings and nationwide clinic roll-up target suicide crisis and bipolar depression.NRXP
ThinkEquity Conference 20243 Feb 2026 - NRX-101 and ketamine advances, plus HOPE spin-out, set the stage for growth and 2025 profitability.NRXP
H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference3 Feb 2026 - Net loss narrowed, new funding secured, and key NDAs for depression therapies advancing in 2024.NRXP
Q2 20241 Feb 2026 - Net loss down 74%, NDA filings and first revenues expected by year-end, profitability in 2025.NRXP
Q3 202413 Jan 2026 - Losses narrowed, NDA filings progressed, and clinic acquisitions target 2025 profitability.NRXP
Q4 202426 Dec 2025 - Registering up to $150M in securities to fund CNS drug development amid significant early-stage risks.NRXP
Registration Filing16 Dec 2025 - Up to $150M in securities registered to fund CNS drug development and corporate growth.NRXP
Registration Filing16 Dec 2025
Next NRx Pharmaceuticals earnings date
Next NRx Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)